The Claim
In rats with ischemia/reperfusion-induced hippocampal injury, administration of BPC 157 is associated with a reduction in the number of red neurons in the CA1 region at 24 and 72 hours post-reperfusion.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In rats suffering brain injury from interrupted blood flow and subsequent restoration, treatment with BPC 157 results in fewer red neurons in the CA1 region of the hippocampus at 24 and 72 hours after blood flow returns.
See the scientific wording
In rats with ischemia/reperfusion-induced hippocampal injury, BPC 157 administration is associated with reduced numbers of 'red neurons'—a histological marker of acute ischemic neuronal death—in the CA1 region at 24 and 72 hours post-reperfusion, indicating attenuation of delayed neuronal damage.
BPC 157 activates a receptor that triggers a chain of signals inside brain cells, boosting a protective form of nitric oxide while blocking a harmful form. This reduces inflammation and oxidative damage, keeping neurons alive after blood flow is restored.
What the research says
1 studyStudy: The effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in rats
In rats with brain injury from blocked blood flow, giving them BPC 157 helped save brain cells in the memory area and made them act normally again. The study showed fewer dead-looking cells when they checked 24 and 72 hours later.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.